medigraphic.com

2025, Número 3

Siguiente >>

Rev Educ Bioquimica 2025; 44 (3)


La ansiedad… ¿Un problema simbiótico?

Calderón SJV, Camacho CR

Idioma: Español
Referencias bibliográficas: 18
Paginas: 144-149
Archivo PDF: 287.72 Kb.


RESUMEN

La microbiota está constituida por la simbiosis con el organismo, de bacterias, hongos, parásitos y virus en coexistencia en forma de mutualismo o de comensales, afectando de manera positiva o negativa la fisiología del organismo. Los efectos de la microbiota pueden ser locales o sistémicos y pueden ser inmunológicos, endocrinos, neurológicos e inflamatorios. Asombrosamente, el metabolismo de la microbiota o su presencia en el intestino, puede afectar la produción de citocinas, quimiocinas y hormonas que afectan los sistemas neurológicos. Los efectos de la microbiota intestinal sobre el sistema nervioso central abre la posibilidad de entender diversas enfermedades, sus aspectos neurofisiológicos y el posible tratamiento coadyuvante con prebióticos y probióticos en enfermedades tan complejas como la ansiedad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Sender R, Fuchs S, Milo R: Revised Estimatesfor the Number of Human and Bacteria Cells in theBody. PLoS Biol 2016, 14(8):e1002533.

  2. Jang HM, Lee HJ, Jang SE, Han MJ, Kim DH:Evidence for interplay among antibacterial-inducedgut microbiota disturbance, neuro-inflammation,and anxiety in mice. Mucosal Immunol 2018,11(5):1386-1397.

  3. Simpson CA, Diaz-Arteche C, Eliby D, SchwartzOS, Simmons JG, Cowan CSM: The gut microbiotain anxiety and depression - A systematic review.Clin Psychol Rev 2021, 83:101943.

  4. Jang HM, Lee KE, Lee HJ, Kim DH:Immobilization stress-induced Escherichia colicauses anxiety by inducing NF-κB activationthrough gut microbiota disturbance. Sci Rep 2018, 8(1):13897.

  5. McGaughey KD, Yilmaz-Swenson T, ElsayedNM, Cruz DA, Rodriguiz RM, Kritzer MD,Peterchev AV, Roach J, Wetsel WC, Williamson DE:Relative abundance of Akkermansia spp. and otherbacterial phylotypes correlates with anxiety- anddepressive-like behavior following social defeat inmice. Sci Rep 2019, 9(1):3281.

  6. Chen YH, Bai J, Wu D, Yu SF, Qiang XL, Bai H,Wang HN, Peng ZW: Association between fecalmicrobiota and generalized anxiety disorder:Severity and early treatment response. J AffectDisord 2019, 259:56-66.

  7. Kouraki A, Kelly A, Vijay A, Gohir S, Astbury S,Georgopoulos V, Millar B, Walsh DA, Ferguson E,Menni C et al: Reproducible microbiomecomposition signatures of anxiety and depressivesymptoms. Comput Struct Biotechnol J 2023,21:5326-5336.

  8. Guo Y, Xie JP, Deng K, Li X, Yuan Y, Xuan Q,Xie J, He XM, Wang Q, Li JJ et al: ProphylacticEffects of. Front Behav Neurosci 2019, 13:126.

  9. Nikel K, Stojko M, Smolarczyk J, Piegza M: TheImpact of Gut Microbiota on the Development ofAnxiety Symptoms-A Narrative Review. Nutrients2025, 17(6).

  10. Pan M, Qian C, Huo S, Wu Y, Zhao X, YingY, Wang B, Yang H, Yeerken A, Wang T et al: Gut-derived lactic acid enhances tryptophan to 5-hydroxytryptamine in regulation of anxiety via. GutMicrobes 2025, 17(1):2447834.

  11. Zhu J, Qi R, Liu Y, Zhao L, Han W:Mechanistic Insights into the Effect of Ligands onStructural Stability and Selectivity ofSulfotransferase 2A1 (SULT2A1). ACS Omega2019, 4(26):22021-22034.

  12. Cao Y, Cheng Y, Pan W, Diao J, Sun L, MengM: Gut microbiota variations in depression andanxiety: a systematic review. BMC Psychiatry 2025,25(1):443.

  13. Duranti S, Ruiz L, Lugli GA, Tames H, MilaniC, Mancabelli L, Mancino W, Longhi G, CarnevaliL, Sgoifo A et al: Bifidobacterium adolescentis as akey member of the human gut microbiota in theproduction of GABA. Sci Rep 2020, 10(1):14112.

  14. Ma T, Jin H, Kwok LY, Sun Z, Liong MT,Zhang H: Probiotic consumption relieved humanstress and anxiety symptoms possibly viamodulating the neuroactive potential of the gutmicrobiota. Neurobiol Stress 2021, 14:100294.

  15. Zhao Z, Xiao G, Xia J, Guo H, Yang X, JiangQ, Wang H, Hu J, Zhang C: Effectiveness ofprobiotic/prebiotic/synbiotic treatments on anxiety:A systematic review and meta-analysis ofrandomized controlled trials. J Affect Disord 2023,343:9-21.

  16. Xu MM, Qiu WH, Ma QY, Yu ZY, Yang WM,Hu TN, Guo Y, Chen XY: Improving precisionmanagement of anxiety disorders: a Mendelianrandomization study targeting specific gutmicrobiota and associated metabolites. FrontMicrobiol 2024, 15:1380912.

  17. Hills RD, Pontefract BA, Mishcon HR, BlackCA, Sutton SC, Theberge CR: Gut Microbiome:Profound Implications for Diet and Disease.Nutrients 2019, 11(7).

  18. Yang Q, Liang Q, Balakrishnan B,Belobrajdic DP, Feng QJ, Zhang W: Role of DietaryNutrients in the Modulation of Gut Microbiota: ANarrative Review. Nutrients 2020, 12(2).




2020     |     www.medigraphic.com